Esoget

Main information

  • Trade name:
  • Esoget 40mg Tablet, delayed release
  • Dosage:
  • 40mg
  • Pharmaceutical form:
  • Tablet, delayed release
  • Units in package:
  • Alu/alu blister pack x 10's (box of 100's)
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • Bafna Pharmaceuticals Ltd.

Documents

Localization

  • Available in:
  • Esoget 40mg Tablet, delayed release
    Philippines
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Anti-Ulcerant
  • Therapeutic indications:
  • For short term treatment of GERD with erosive esophagitis in adults and pediatric patients 1 month to 17 years, inclusively as an alternative to oral therapy when oral esomeprazole is not possible or appropriate.

Status

  • Source:
  • FDA - Food And Drug Administration - Philippines
  • Authorization number:
  • DRP-6336
  • Authorization date:
  • 11-09-2018
  • Last update:
  • 19-05-2017